Date of publication: February 14,
2006
Source:
http://gmoinfo.jrc.it/gmp_browse_geninf.asp
Notification number:
B/SE/06/724
Member State:Sweden
Date of Acknowledgement:01/02/2006
Title of the Project:
Notification for the deliberate release of Oilseed Rape lines
genetically modified for increased and stable grain yield
Proposed period of release From:01/01/2006
To:31/12/2010
Name of the Institute(s) or Company(ies): Plant
Science Sweden AB;
3. Is the same GMPt release planned elsewhere in the
Community?
Not known
4 - Has the same GMPt been notified elsewhere by the same
notifier?
Yes
If yes, notification number(s):
-
Other notifications
05-BAS1-037-CAN01-0983-MB004-01;
05-BAS1-037-CAN02-0984-MB004-01; 05-BAS1-037-CAN03-0985-MB004-01
Genetically
modified plant
1. Complete name of the
recipient or parental plant(s)
|
Common Name
|
Family Name
|
Genus |
Species
|
Subspecies
|
Cultivar/breeding line
|
| spring
oilseed rape |
brassicaceae |
brassica |
brassica napus |
napus
(syn. oleifera) |
Westar
|
2. Description of the traits and characteristics which have
been introduced or modified, including marker genes and previous
modifications:
- improved and stabilized grain yield in spring oilseed rape
under a range of environment conditions
- neomycin phosphotransferase II gene as selectable marker gene
to identify transgenic cells in tissue culture
Genetic
modification
3. Type of genetic
modification:
Insertion;
4. In case of insertion of genetic material, give the source
and intended function of each constituent fragment of the region
to be inserted:
T-DNA borders, from pTiT37, for incorporation into plant
chromosome
Trait genes used:
# a gene involved in Polyamine metabolism from Saccharomyces
cerevisiae
# a gene involved in hydrolysis of proteins from Saccharomyces
cerevisiae
# a cell fusion protein gene from Saccharomyces cerevisiae
# a GTP binding protein gene from Physcomitrella patens
# a gene involved in prenylation of proteins from Arabidopsis
thaliana
- promoter of the 34S gene from Figwort Mosaic Virus (FMV) or
promoter of the nitrilase 1 gene from Arabidopsis thaliana
- terminator of the 35S gene from the Cauliflower mosaic virus
or the terminator of the nopaline synthase gene from A.
tumefaciens
Selectable marker gene used:
# neomycin phosphotransferase II gene, kanamycin tolerance in
plant material
- promoter and terminator from nopaline synthase gene, A.
tumefaciens, gene regulation
6. Brief description of the method used for the genetic
modification:
A standard Agrobacterium tumefaciens based transformation
system was used for transformation of spring oilseed rape cv.
Westar according to Molony et al. (1989) and Hoekema (1983).
7. If the recipient or parental plant is a forest tree
species, describe ways and extent of dissemination and specific
factors affecting dissemination:
Not applicable.
Experimental
Release
1. Purpose of the release:
Seed Multiplication and evaluation of general phenotype and
yield components under field conditions and selection of lines
for further testing and analysis of the trait.
2. Geographical location of the site:
Municipalities of Vara, Klippan, Kristianstad, Svalöv and
Eslöv.
3. Size of the site (m2):
The total trial area will not exceed 15 ha (150000 m2) in
total over the five years.
4. Relevant data regarding previous releases carried out with
the same GM-plant, if any, specifically related to the potential
environmental and human health impacts from the release:
Three out of the five genes of interest have been previously
grown in field releases with genetically modified oilseed rape
lines in Manitoba, Canada 2005 (05-BAS1-037). No adverse impacts
on the environment or human health have been recorded.
Environmental
Impact and Risk Management
Summary of the potential
environmental impact from the release of the GMPts:
The genetically modified oilseed rape lines are expected to
show an improved biomass production under drought and improved
seed yield and quality. No difference regarding persistence or
invasiveness in natural habitats compared to conventional spring
oilseed rape is expected. It is expected that a selective
advantage is conferred to the GM lines via the introduced trait
under agricultural production. Due to the measures to be taken
during the release (distance to or absence of cultivated and
wild relatives, use of insect proof tents) the potential for
gene transfer will be virtually excluded. Interactions of the GM
oilseed rape lines with non-target species and resulting effects
will be comparable to those of conventional oilseed rape
varieties. The potential of increased seed yield resulting in
any effects on animal or human health from contact or
consumption is considered negligible. Measures in place under
current field trials in relation to handling, harvest, storing,
transport or disposition will further minimize the possibility
of any adverse effects on health or environment. No effects are
expected on biogeochemical processes from the predicted trait.
The GM oilseed rape lines will be cultivated under conventional
agricultural practices.
Brief description of any measures taken for the management of
risks:
The distance from the nearest cultivation of oilseed rape
plants will be at least 200 m. A 6m-wide protective border
containing unmodified male-sterile rape will surround
experimental areas. All genetically modified lines including
their non-transgenic offspring will be grown under insect-proof
tents. Sowing and harvesting machinery will be cleaned on site
to prevent the dispersal of GM seed. Harvested seed material
will be transported from the site in closed and labeled
containers to the laboratories for analyses. Remaining seed will
be inactivated. Vegetative plant material will be chopped and
worked into the soil. The area will be controlled for volunteers
for a period of 4 consecutive years. During the release period
the trial site will be monitored at defined intervals.
Summary of foreseen field trial studies focused to gain new
data on environmental and human health impact from the release:
Not applicable.
Final report
-
European
Commission administrative information
Consent given by the Competent
Authority: Not Known |
